Fang Liu

4PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 25, 2022
Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas.

Gerhard Jungwirth, Tao Yu, Fang Liu

|Sep 07, 2020
A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.

Jie Xu, Fang Liu, Yuntao Li

Pageof 1